Key points are not available for this paper at this time.
Design
Editorial
Answers are grounded in this paper and cite their sources.
Highlights the importance of patient-reported outcomes (PROs) alongside hard clinical endpoints in cardiovascular trials.
eductions in hard clinical end points such as mortality, myocardial infarction (MI), repeat revascularization, and stroke are a major focus of cardiovascular clinical trials, routine clinical care, and population health management.However, improvements in symptom burden, quality of life, and functional status are also consequential to patients, clinicians, and health care systems.Complementary to hard clinical end points, patientreported outcomes (PROs) measure a patient's health status, are obtained directly from a patient, and are used to describe quality-of-life-related outcomes.
No takes yet. Share an insight, caveat, or question.
Genders et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: